Breast Flashcards
Ductal carcinoma in situ characteristics
Arises from ductal atypia
Neoplastic cells fill ductal lumen but there is no BM penetration or lump formation
Unilateral and unifocal
How does DCIS appear on mammography
Microcalcifications
What is comedocarcinoma
Subtype of breast DCIS with central necrosis, dystrophic calcifications
Lobular carcinoma in situ characteristics
Neoplastic cells fill lobules. No BM penetration.
Multifocal and bilateral
LCIS mammogram appearance
Nothing at all (incidental biopsy finding)
Pagets disease of the breast characteristics
Spread of DCIS/invasive breast carcinoma that has spread through lactiferous duct to contiguous skin of nipple and areola producing eczematous lesions
Intraepithelial adenocarcinoma
Invasive ductal carcinoma
Glandular duct like aggressive malignant cells that have invaded BM in desmoplastic stroma producing a hard/firm/fibrous mass with sharp edges.
What is the MC kind of invasive breast cancer
Invasive ductal carcinoma
Invasive lobular carcinoma of breast characteristics
Malignant cells with low E cadherin expression forming orderly lines
No desmoplastic response or gland-like cells
Medullary breast cancer characteristics
Large anaplastic cells with associated plasma cells and LOs forming sheets and presenting as a well circumscribed soft mass with smooth edges + hyperplastic LNs
What is a DDx for medullary breast cancer
Fibroadenoma
What genes are associated with medullary breast cancer
BRCA1
Triple negative type
What causes inflammatory breast cancer and what is the prognosis
Tumour has invaded dermal lymphatics resulting in oedema, erythema, puckering and p’eau d’orange of the skin. Poor prognosis.
Mucinous breast cancer characteristics
Abundant extracellular mucin
Older women
Tubular breast cancer characteristics
Well differentiated tubules that lack myoepithelium
What are the molecular and biological subtypes of breast cancers
Luminal A = ER+/PR+/HER2-
Luminal B = ER+/PR+/HER2-
HER2 = HER2+ (+/- PR+ +/- ER+)
TNBC/Basal = HER2-/ER-/PR-
What is HER2
Human epidermal growth factor receptor 2
Who does luminal A type breast cancer effect
Where does it met
What is it’s prognosis and response to Tx
Older women
Bone > viscera > brain
Long survival
Poor chemo response but good endocrine therapy response
Who does luminal B type breast cancer effect
Where does it met
What is it’s prognosis and response to Tx
BRCA2 carriers
Bone > viscera > brain
Early recurrence at less < 10 years
Medium response to chemo and good response to endocrine therapy
Who does HER2 type breast cancer effect
Where does it met
What is it’s prognosis and response to Tx
Young women
Bone, brain and viscera
Good response to chemo but variable response to endocrine therapy
Bimodal recurrence (early and late)
Who does basal type breast cancer effect
Where does it met
What is it’s prognosis and response to Tx
Young women and BRCA1 holders
Bone, brain and viscera
Medullary and metaplastic cancer with a good response to chemo but poor response to endocrine therapy
Early recurrence and survival with mets is rare
Describe early stage breast cancer
Stage 0-2: confined to breast +/- up to 3 axillary/mammary LNs involved +/- micrometastases
0 = DCIS
1 = invasive carcinoma 2cm or less with no LN involvement or micromets to LNs
2 = invasive carcinoma > 2cm but < 5cm with 0-3 LNs involved
Describe locally advanced breast cancer
Stage 3
- Large size > 5cm +/- LNs
- Any size with skin/chest wall involvement
- Any size inflammatory carcinoma
Describe advanced breast cancer
Stage 4 = distant metastasis (bone, brain, lungs, liver)
What is neoadjuvant therapy and when is it used in breast cancer
Treatment delivered before primary Tx to reduce the size of the tumour or kill cancer cells that have spread
Neoadjuvant chemo is most commonly used with TNBC, HER2, type or locally advanced ER+/-PR+/HER2- cancers
What are the advantages of neoadjuvant therapy in breast cancer
- Making an inoperable tumour operable
- Making a large tumour small enough for breast conserving therapy
- Reducing risk of death from distant metastases
How does breast cancer staging occur
- Core biopsy with immunohistochemical staining for receptor status
- USS/CT/exam for LNs + intraoperative
- Distant metastasis
- CXR
- Abdo, chest, pelvis CT
- Brain MRI
What are risk factors for male breast cancer
Most important = germline mutation in BRCA 2
Obesity
Infertility
Klinefelter syndrome
Exogenous oestrogen exposure
Prior benign breast disease
Chest wall radiation
Alcohol consumpion
Increasing age
First degree relative with breast cancer
Where does breast pain usually occur
Upper outer quadrant
Key features of mastalgia
Cyclical/non-cyclical
Focal/unilateral/bilateral
Causes of breast pain
Cyclical breast pain: hormones and menstrual cycle (can decrease with pregnancy/menopause)
Pregnancy
Menopause
Oestrogen/progesterone containing medications
Large breasts may produce non-cyclical breast pain
Non-cyclical breast pain may be from breat or referred from OA of thoracic spine or underlying MSK pain
Mastitis or breast abscess (redness/tender lump)
Males: physiological or diuretic related/medication related gynecomastia
Investigation of mastalgia
Imaging not indicated unless associated with lump or other signs raising suspicion of breast ca (eczematous rash/nipple retraction/bloody serous discharge/inflammation not responding to Tx etc.) or is a focal Sx in ppl > 50yo
Mx of mastalgia
- Reassurance
- Well fitted sports bra/non-underwire bra
- Topical NSAID gel
- Stopping/reducing hormonal meds
- Increasing soy, reducing caffeine and salt
- Evening primrose oil
How should a new breast Sx be investigated
The triple test
- Hx and clinical breast exam
- Imaging = mammography and/or USS
- Non-excisional biopsy = core biopsy and/or FNA cytology
Presenting symptoms of breast cancer
MC = new breast lump
Thickening or ridge
Breast of nipple asymmetry
Skin changes e.g., dimpling, redness,
Nipple changes
Nipple discharge
Unilateral breast pain
Next step: If on Hx and Ex there is no breast lump/discrete lesion and findings consistent with hormonal change:
Mammogram if DUE
Tx pain
Review in 6-8 weeks (immediately after period)
If problem persists refer for imaging
Next step: clinically benign breast mass/nipple change on Hx or Ex
Imaging
Next step: Clinically inconclusive on Hx and breast exam
Imaging
Next step: Suspicious or malignant breast or nipple change
Refer to breast surgeon and organise imaging
Next step: Normal breast tissue/no discrete lesion on imaging
If consistent with clinical findings:
- Reassure
- Advise RE breast awareness
- Advise RE future screening
If inconsistent with clinical findings:
- Non-excisional biopsy
Next step: If benign findings on breast imaging
Simple (asymptomatic) cyst: FNA
Solid lesion/complex cyst: Non-excisional biopsy = core or FNA cytology